The Library
Clinical trials in critical care : can a Bayesian approach enhance clinical and scientific decision making?
Tools
Yarnell, Christopher J., Abrams, Darryl, Baldwin, Matthew R., Brodie, Daniel, Fan, Eddy, Ferguson, Niall D., Hua, May, Madahar, Purnema, McAuley, Danny F., Munshi, Laveena, Perkins, Gavin D., Rubenfeld, Gordon, Slutsky, Arthur S., Wunsch, Hannah, Fowler, Robert A., Tomlinson, George, Beitler, Jeremy R. and Goligher, Ewan C. (2021) Clinical trials in critical care : can a Bayesian approach enhance clinical and scientific decision making? Lancet Respiratory Medicine, 9 (2). pp. 207-216. doi:10.1016/S2213-2600(20)30471-9 ISSN 2213-2600.
|
PDF
WRAP-comparing-bayesian-frequentist-analyses-critical-care-studies-Perkins-2020.pdf - Accepted Version - Requires a PDF viewer. Download (698Kb) | Preview |
|
|
PDF
Bayesian Reanalysis Supplement.pdf - Supplemental Material - Requires a PDF viewer. Download (2823Kb) | Preview |
Official URL: https://doi.org/10.1016/S2213-2600(20)30471-9
Abstract
Recent Bayesian reanalyses of prominent trials in critical illness have generated controversy by contradicting the initial frequentist conclusions. Many clinicians may be skeptical that Bayesian analysis, a philosophical and statistical approach that combines prior beliefs with data to generate probabilities, provides more useful information about the meaning of clinical trials than the conventional frequentist approach. In this Personal View we introduce clinicians to the rationale, process, and interpretation of Bayesian analysis through a systematic review and reanalysis of interventional trials in critical illness. In the majority of cases, Bayesian and frequentist analyses agreed. In the remainder, Bayesian analysis identified interventions where benefit was probable despite the absence of statistical significance, where interpretation depended substantially on choice of prior distribution, and where benefit was improbable despite statistical significance. Bayesian analysis in critical care medicine can help distinguish harm from uncertainty and establish the probability of clinically important benefit for clinicians, policymakers, and patients.
Item Type: | Journal Article | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Subjects: | R Medicine > RB Pathology | |||||||||||||||||||||
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Clinical Trials Unit Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
|||||||||||||||||||||
Library of Congress Subject Headings (LCSH): | Critical care medicine -- Statistical methods, Bayesian statistical decision theory, Clinical trials -- Evaluation -- Statistical methods, Clinical trials -- Statistical methods | |||||||||||||||||||||
Journal or Publication Title: | Lancet Respiratory Medicine | |||||||||||||||||||||
Publisher: | Elsevier | |||||||||||||||||||||
ISSN: | 2213-2600 | |||||||||||||||||||||
Official Date: | 1 February 2021 | |||||||||||||||||||||
Dates: |
|
|||||||||||||||||||||
Volume: | 9 | |||||||||||||||||||||
Number: | 2 | |||||||||||||||||||||
Page Range: | pp. 207-216 | |||||||||||||||||||||
DOI: | 10.1016/S2213-2600(20)30471-9 | |||||||||||||||||||||
Status: | Peer Reviewed | |||||||||||||||||||||
Publication Status: | Published | |||||||||||||||||||||
Access rights to Published version: | Restricted or Subscription Access | |||||||||||||||||||||
Copyright Holders: | © 2020 Elsevier Ltd. All rights reserved. | |||||||||||||||||||||
Date of first compliant deposit: | 16 December 2020 | |||||||||||||||||||||
Date of first compliant Open Access: | 20 May 2021 | |||||||||||||||||||||
RIOXX Funder/Project Grant: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |
Downloads
Downloads per month over past year